Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR, Schwarzenberger P, van den Berg WB, Lubberts E. Koenders MI, et al. Among authors: van den bersselaar l, van den berg wb. Arthritis Rheum. 2005 Oct;52(10):3239-47. doi: 10.1002/art.21342. Arthritis Rheum. 2005. PMID: 16200598 Free article.
Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
Abdollahi-Roodsaz S, Joosten LA, Helsen MM, Walgreen B, van Lent PL, van den Bersselaar LA, Koenders MI, van den Berg WB. Abdollahi-Roodsaz S, et al. Among authors: van den bersselaar la, van lent pl, van den berg wb. Arthritis Rheum. 2008 Dec;58(12):3753-64. doi: 10.1002/art.24127. Arthritis Rheum. 2008. PMID: 19035506 Free article.
Toll-like receptor 2 controls acute immune complex-driven arthritis in mice by regulating the inhibitory Fcγ receptor IIB.
Abdollahi-Roodsaz S, Koenders MI, Walgreen B, Bolscher J, Helsen MM, van den Bersselaar LA, van Lent PL, van de Loo FA, van den Berg WB. Abdollahi-Roodsaz S, et al. Among authors: van den bersselaar la, van lent pl, van de loo fa, van den berg wb. Arthritis Rheum. 2013 Oct;65(10):2583-93. doi: 10.1002/art.38087. Arthritis Rheum. 2013. PMID: 23860661 Free article.
Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL, Barrera P, van den Berg WB. Joosten LA, et al. Among authors: van den bersselaar la, van lent pl, van riel pl, van den berg wb. Arthritis Rheum. 2003 Feb;48(2):339-47. doi: 10.1002/art.10814. Arthritis Rheum. 2003. PMID: 12571842 Free article.
Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.
Joosten LA, Smeets RL, Koenders MI, van den Bersselaar LA, Helsen MM, Oppers-Walgreen B, Lubberts E, Iwakura Y, van de Loo FA, van den Berg WB. Joosten LA, et al. Among authors: van den bersselaar la, van de loo fa, van den berg wb. Am J Pathol. 2004 Sep;165(3):959-67. doi: 10.1016/S0002-9440(10)63357-3. Am J Pathol. 2004. PMID: 15331419 Free PMC article.
T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
Joosten LA, Abdollahi-Roodsaz S, Heuvelmans-Jacobs M, Helsen MM, van den Bersselaar LA, Oppers-Walgreen B, Koenders MI, van den Berg WB. Joosten LA, et al. Arthritis Rheum. 2008 Jan;58(1):98-108. doi: 10.1002/art.23152. Arthritis Rheum. 2008. PMID: 18163514 Free article.
Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
Lubberts E, Oppers-Walgreen B, Pettit AR, Van Den Bersselaar L, Joosten LA, Goldring SR, Gravallese EM, Van Den Berg WB. Lubberts E, et al. Among authors: van den bersselaar l, van den berg wb. Arthritis Rheum. 2002 Nov;46(11):3055-64. doi: 10.1002/art.10607. Arthritis Rheum. 2002. PMID: 12428250 Free article.
Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB. Lubberts E, et al. Among authors: van den bersselaar l, van den berg wb. Arthritis Rheum. 2004 Feb;50(2):650-9. doi: 10.1002/art.20001. Arthritis Rheum. 2004. PMID: 14872510 Free article.
74 results